Thyroid nodules are common, and most of them are benign. However, 7-15% of thyroid nodules represent malignancy. It is essential to assess the degree of and future risk of mass effect, excluding thyroid cancer, and follow up the therapy response, especially for thyroid cancer. Fine-needle aspiration (FNA) is a sensitive test for diagnosing thyroid mass. However, sometimes it becomes tricky to differentiate benign from malignant follicular nodules, which give equivocal results.
Thyroid scintigraphy (TS) is a method to evaluate the thyroid gland's functional and morphologic aspects. Even though the spatial resolution is less than thyroid ultrasound (5-7 mm vs. 1 mm), available information remains clinically relevant. Moreover, radiopharmaceuticals as tracers can evaluate the proliferation of cold thyroid nodules, supporting the management of indeterminate cytology results and limiting unnecessary surgeries. Advancements in thyroid imaging modalities are also followed by a new treatments approach and follow-up therapy responses.
This collection comprehensively reviews thyroid nodules imaging for diagnostic and therapy response. This research topic will include basic, translational, and clinical findings to overview the latest imaging modalities innovative approaches. The research topic invites, but is not limited to, the following research aspects:
• Advances in imaging to differentiate benign and malignant thyroid nodules;
• Innovative thyroid imaging approaches for therapy and therapy responses.
Thyroid nodules are common, and most of them are benign. However, 7-15% of thyroid nodules represent malignancy. It is essential to assess the degree of and future risk of mass effect, excluding thyroid cancer, and follow up the therapy response, especially for thyroid cancer. Fine-needle aspiration (FNA) is a sensitive test for diagnosing thyroid mass. However, sometimes it becomes tricky to differentiate benign from malignant follicular nodules, which give equivocal results.
Thyroid scintigraphy (TS) is a method to evaluate the thyroid gland's functional and morphologic aspects. Even though the spatial resolution is less than thyroid ultrasound (5-7 mm vs. 1 mm), available information remains clinically relevant. Moreover, radiopharmaceuticals as tracers can evaluate the proliferation of cold thyroid nodules, supporting the management of indeterminate cytology results and limiting unnecessary surgeries. Advancements in thyroid imaging modalities are also followed by a new treatments approach and follow-up therapy responses.
This collection comprehensively reviews thyroid nodules imaging for diagnostic and therapy response. This research topic will include basic, translational, and clinical findings to overview the latest imaging modalities innovative approaches. The research topic invites, but is not limited to, the following research aspects:
• Advances in imaging to differentiate benign and malignant thyroid nodules;
• Innovative thyroid imaging approaches for therapy and therapy responses.
